This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Shandong Danhong Pharmaceutical Co., Ltd.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Yongbo Fang - Innovator in Pharmaceutical Chemistry
Introduction
Yongbo Fang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on drug analogs. His expertise and dedication to research have led to the development of valuable compounds that can enhance therapeutic options.
Latest Patents
Yongbo Fang holds a patent for a Dezocine analog. The patent discloses compounds represented by formula (I), (II), and (III), along with their pharmaceutically acceptable salts or tautomers. This innovation has the potential to impact pain management and improve patient outcomes.
Career Highlights
Yongbo Fang is currently employed at Shandong Danhong Pharmaceutical Co., Ltd. His role at the company allows him to engage in cutting-edge research and development, contributing to the advancement of pharmaceutical products. His work is characterized by a commitment to improving drug efficacy and safety.
Collaborations
Yongbo Fang collaborates with talented colleagues, including Shuhui Chen and Wentao Wu. Together, they work on various projects that aim to push the boundaries of pharmaceutical innovation.
Conclusion
Yongbo Fang's contributions to the field of pharmaceutical chemistry, particularly through his Dezocine analog patent, highlight his role as an influential inventor. His work continues to pave the way for advancements in drug development and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile